Key statistics
As of last trade, Glaukos Corp (6GJ:FRA) traded at 91.50, 44.09% above the 52 week low of 63.50 set on Oct 27, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 91.50 |
|---|---|
| High | 91.50 |
| Low | 91.50 |
| Bid | 91.00 |
| Offer | 93.50 |
| Previous close | 89.00 |
| Average volume | 51.14 |
|---|---|
| Shares outstanding | 57.43m |
| Free float | 55.44m |
| P/E (TTM) | -- |
| Market cap | 6.29bn USD |
| EPS (TTM) | -1.55 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:42 GMT.
More ▼
Press releases
- Glaukos Announces US FDA Approval of NDA Supplement Allowing for Re-Administration of iDose® TR
- Glaukos to Release Fourth Quarter and Full Year 2025 Financial Results after Market Close on February 17
- Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance
- Glaukos Announces Participation in J.P. Morgan Healthcare Conference
